Pancreatic Cancer Research

ResearcherUniversity of CoimbraActive in the last 2 years

Ana Cláudia Paiva‐Santos

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2710-6000; OpenAlex author ID A5077489697. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2023: 1 paper · 2024: 2 papers · 2025: 3 papers · 2026: 1 paper

Papers 7

  1. Corrigendum to "Cancer cell membrane-modified Soluplus® micelles for gemcitabine delivery to pancreatic cancer using a prodrug approach" [Int. J. Pharm. 662 (2… Co-author DOI 10.1016/j.ijpharm.2026.127439↗
  2. Biomimetic nanosystems for pancreatic cancer therapy: A review. Co-author DOI 10.1016/j.jconrel.2025.113824↗
  3. Enzyme-responsive vitamin D-based micelles for paclitaxel-controlled delivery and synergistic pancreatic cancer therapy. Co-author DOI 10.1016/j.mtbio.2025.101555↗
  4. Biomimetic cancer cell membrane-enriched vitamin E-stapled gemcitabine-loaded TPGS micelles for pancreatic cancer therapy. Co-author DOI 10.1080/10717544.2025.2527759↗
  5. Cancer cell membrane-modified Soluplus® micelles for gemcitabine delivery to pancreatic cancer using a prodrug approach. Co-author DOI 10.1016/j.ijpharm.2024.124529↗
  6. Gemcitabine-Vitamin E Prodrug-Loaded Micelles for Pancreatic Cancer Therapy. Co-author DOI 10.3390/pharmaceutics16010095↗
  7. Liposome-based diagnostic and therapeutic applications for pancreatic cancer. Last author DOI 10.1016/j.actbio.2022.12.013↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Carmen Alvarez‐Lorenzo · 6 shared papers, 2024–2026 · strength 1.65
  2. Miguel Pereira‐Silva · 6 shared papers, 2023–2026 · strength 1.55
  3. Bárbara Blanco‐Fernandez · 4 shared papers, 2024–2026 · strength 1.09
  4. Diana Peixoto · 2 shared papers, 2023–2025 · strength 0.43
  5. João M. J. M. Ravasco · 1 shared paper, 2025 · strength 0.27
  6. João Conde · 1 shared paper, 2025 · strength 0.27
  7. Faisal Raza · 1 shared paper, 2023 · strength 0.17
  8. Clare Hoskins · 1 shared paper, 2023 · strength 0.17
  9. Abbas Rahdar · 1 shared paper, 2023 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.